Cited by 2,054COVID-19 Clinical Research StudiesVenous Thromboembolism Diagnosis and ManagementLong-Term Effects of COVID-19

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy

Open access
Lodigiani, Corrado, Iapichino, Giacomo, Carenzo, Luca, Cecconi, Maurizio, Ferrazzi, Paola, Sebastian, Tim, Kucher, Nils, Studt, Jan-Dirk +4 more·2020·Thrombosis Research

Abstract

Background Few data are available on the rate and characteristics of thromboembolic complications in hospitalized patients with COVID-19.Methods We studied consecutive symptomatic patients with laboratory-proven COVID-19 admitted to a university hospital in Milan, Italy (13.02.2020-10.04.2020). The primary outcome was any thromboembolic complication, including venous thromboembolism (VTE), ischemic stroke, and acute coronary syndrome (ACS)/myocardial infarction (MI). Secondary outcome was overt disseminated intravascular coagulation (DIC).Results We included 388 patients (median age 66 years, 68% men, 16% requiring intensive care [ICU]). Thromboprophylaxis was used in 100% of ICU patients and 75% of those on the general ward. Thromboembolic events occurred in 28 (7.7% of closed cases; 95%CI 5.4%-11.0%), corresponding to a cumulative rate of 21% (27.6% ICU, 6.6% general ward). Half of the thromboembolic events were diagnosed within 24 h of hospital admission. Forty-four patients underwent VTE imaging tests and VTE was confirmed in 16 (36%). Computed tomography pulmonary angiography (CTPA) was performed in 30 patients, corresponding to 7.7% of total, and pulmonary embolism was confirmed in 10 (33% of CTPA). The rate of ischemic stroke and ACS/MI was 2.5% and 1.1%, respectively. Overt DIC was present in 8 (2.2%) patients.Conclusions The high number of arterial and, in particular, venous thromboembolic events diagnosed within 24 h of admission and the high rate of positive VTE imaging tests among the few COVID-19 patients tested suggest that there is an urgent need to improve specific VTE diagnostic strategies and investigate the efficacy and safety of thromboprophylaxis in ambulatory COVID-19 patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.thromres.2020.04.024

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AMI has been described in patients with COVID-19, probably related to large vessel thromboembolic events as well as to small vessel thrombosis linked to hypercoagulability and fibrinolysis shutdown.

    “AMI has been described in patients with coronavirus disease (COVID -19), probably related to large vessel thromboembolic events as well as to small vessel thrombosis linked to hypercoagulability and fibrinolysis shutdown [36].”

    From Acute mesenteric ischemia: updated guidelines of the World Society of Emergency Surgery. (2022) · cites this paper as [36]

    The Results report thromboembolic events in patients with COVID-19, including acute coronary syndrome/myocardial infarction, and the Discussion describes coagulation activation. The paper does not report acute mesenteric ischemia, if that is what AMI denotes here, or link it to large- or small-vessel thrombosis or fibrinolysis shutdown. No page numbers are available in our copy. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lodigiani, C., Iapichino, G., Carenzo, L., Cecconi, M., Ferrazzi, P., Sebastian, T., Kucher, N., Studt, J.-D., Sacco, C., Bertuzzi, A., Sandri, M. T., & Barco, S.
Affiliations
  • Humanitas University (IT)
  • IRCCS Humanitas Research Hospital (IT)
  • University Hospital Zurich (CH)
  • Johannes Gutenberg University Mainz (DE)
Corresponding author
Lodigiani, Corrado
Venue
Thrombosis Research
Publisher
Elsevier BV
Published
2020-07
Volume
191
Pages
9-14
ISSN
0049-3848 (ISSN-L)
OpenAlex
W3019953082
Cited by
2,054
References
20
Citations by year
2026: 17 · 2025: 44 · 2024: 94 · 2023: 186 · 2022: 389 · 2021: 632 · 2020: 689 · 2012: 1
FWCI
62.11
Type
journal article
Language
en
Open access
Locations
  • Thrombosis Research (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Bundesministerium für Bildung und Forschung (01EO1503, 01EO1003)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
Keywords
COVID-19 pandemic, venous thromboembolism, arterial thromboembolism, pulmonary embolism, ischemic stroke, acute coronary syndrome, myocardial infarction, disseminated intravascular coagulation, thromboprophylaxis, hospitalized patients
MeSH terms
COVID-19, Aged, Aged, 80 and over, Ambulatory Care, Anticoagulants, Arterial Occlusive Diseases, Brain Ischemia, Coronary Thrombosis, Critical Care, Disseminated Intravascular Coagulation, Female, Hospitals, Teaching, Hospitals, Urban, Humans, Italy, Length of Stay, Male, Middle Aged, Patient Admission, Pneumonia, Viral, Pulmonary Embolism, Retrospective Studies, Risk Factors, Comorbidity, Hospital Mortality, Coronavirus Infections, Thrombophilia, Acute Coronary Syndrome, Venous Thromboembolism, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review